Related Experiment Video
Updated: Aug 5, 2026
The Measurement and Treatment of Suppression in Amblyopia
Published on: December 14, 2012
Tackling amblyopia in human infants
1Cerveau et Vision, INSERM Unité 371, Lyon-Sud, France. vital@lyon151.inserm.fr
Insights
Early detection of amblyopia (lazy eye) is crucial. This study found anisometropia to be the primary risk factor, supporting universal infant screening for better vision outcomes.
Area of Science:
- Ophthalmology
- Pediatric Medicine
- Public Health
Background:
- Amblyopia, or lazy eye, is a leading cause of preventable vision impairment in children.
- Early detection and treatment are key to preventing permanent vision loss.
- The optimal screening strategy, universal versus targeted, remains debated.
Purpose of the Study:
- To investigate risk factors for amblyopia in infants.
- To determine the most effective approach for amblyopia screening in a general infant population.
Main Methods:
- A population-based study involving 2143 infants aged 5-15 months.
- Utilized odds ratio analysis to identify risk factors.
- Infants were part of a routine health surveillance program.
Main Results:
- Anisometropia was identified as the strongest risk factor for developing amblyopia.
- Family history of visual defects showed a 'protective' effect, likely due to earlier parental-initiated check-ups.
- These findings support the need for comprehensive refractive error screening.
Conclusions:
- Universal screening for refractive and resolution defects in infants is necessary.
- Early identification of conditions like anisometropia can guide timely intervention.
- The study supports recent French health authority decisions for mandatory 9-month infant visual assessments.
Abstract:
Amblyopia can possibly be avoided if it is detected early and treated appropriately. It remains to be decided whether the general population should be screened or whether a subpopulation of infants likely to develop this pathology can be isolated. A population study using the odds ratio was performed on a group of unselected infants (n = 2143) aged 5-15 months who attended a surveillance programme. Results show that a family history of visual defect has a 'protective' effect on individual infants, most probably because more of these infants are brought in for a check-up at an early age on the parents' initiative. The risk factor with the highest predisposition for amblyopia was found to be anisometropia. These results indicate the necessity for screening of refraction and resolution defects in the whole population. The French health authorities have recently decided to provide for a visual assessment visit to all infants at the age of 9 months.
